 | Up a level |
von Garnier, C; Rothen-Rutishauser, B; Fink, A (2012). A particular therapy. International Innovation.
Rothen-Rutishauser, B; Clift, MJD; Jud, C; Fink, A; Wick, P (2012). Human epithelial cells in vitro - are they an advantageous tool to help understand the nanomaterial biological barrier interaction? EURO-NanoTox-Letters, 4((1)), pp. 1-20. Graz: BioNanoNet Forschungsgesellschaft
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Geiser, T; Nicod, LP; von Garnier, C (2010). Dendritic cells exposed to biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. American journal of respiratory and critical care medicine, 181(A3096) New York, N.Y.: American Lung Association
Meili, D; Broers, B; Bruggmann, P; Fink, A; Hämmig, R (2008). Medizinische Empfehlungen für substitutionsgestützte Behandlungen (SGB) bei Opioidabhängigkeit - Erstellt durch die Schweizerische Gesellschaft für Suchtmedizin. Suchtmedizin in Forschung und Praxis, 10(1), pp. 29-53. Landsberg: ecomed Medizin
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: , (ed.) Swiss Society for Pneumology. Lausanne: Swiss Society for Pneumology
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: European Respiratory Society Annual Conference. Barcelona, Spain: European Respiratory Society Annual Conference
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: 11th International Symposium on dendritic cells in fundamental and clinical immunology. Lugano.
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: Day of clinical research at the Bern University. Bern: Day of clinical research at the Bern University
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, V; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2009). Dendritic cells exposed to biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. In: Conference of the American Thoracic Society. San Diego.
von Garnier, C; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T (2009). Exposure of dendritic cells to biomedical nanoparticles down-regulates antigen-specific CD4+ T cell stimulation. In: International conference of the European Respiratory Society. Wien.
